Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop A32, Atlanta, GA 30329, USA.
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop A32, Atlanta, GA 30329, USA.
Infect Dis Clin North Am. 2018 Mar;32(1):75-89. doi: 10.1016/j.idc.2017.11.005.
Influenza vaccination is recommended for all children 6 months of age and older who do not have contraindications. This article provides an overview of information concerning burden of influenza among children in the United States; US-licensed influenza vaccines; vaccine immunogenicity, effectiveness, and safety; and recent updates relevant to use of these vaccines in pediatric populations. Influenza antiviral medications are discussed. Details concerning vaccine-related topics may be found in the current US Centers for Disease Control and Prevention/Advisory Committee on Immunization Practices recommendations for use of influenza vaccines (https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html). Additional information on influenza antivirals is located at https://www.cdc.gov/flu/professionals/antivirals/index.htm.
流感疫苗推荐用于所有无禁忌证的 6 月龄及以上儿童。本文概述了美国儿童中流感的负担、美国许可的流感疫苗、疫苗的免疫原性、有效性和安全性，以及与儿科人群使用这些疫苗相关的最新更新。本文还讨论了流感抗病毒药物。疫苗相关主题的详细信息可在当前美国疾病控制与预防中心/免疫实践咨询委员会推荐使用流感疫苗的建议中找到（https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html）。有关流感抗病毒药物的更多信息，请访问 https://www.cdc.gov/flu/professionals/antivirals/index.htm。
